Stereocontrolled Construction of Quaternary Stereocenters
(major diastereoisomer)=17.4 min (major), 35.6 min
(minor); HR-MS: m/z=376.1154, calcd. for (C20H19NO5 +
Na): 376.1161.
75.0 min (minor); HR-MS: m/z=451.1634, calcd. for
(C23H25FN2O5 +Na): 451.1645.
AHCTUNGERTG(NNUN 2S,3R)-Methyl 1-[1-(4-chlorophenyl)-2-nitroethyl]-2-oxo-
A
cyclopentanecarboxylate (5b): [a]2D5: +36.2 (c 1.6, CHCl3,
91% ee) (lit.[8] [a]D25: À39.6, 96% ee, dr>20:1); 1H NMR
(300 MHz, CDCl3): d=1.82–2.13 (m, 4H), 2.35–2.45 (m,
2H), 3.75 (s, 3H), 4.04 (dd, J=11.0, 3.9 Hz, 1H), 4.98 (dd,
J=13.6, 11.0 Hz, 1H), 5.15 (dd, J=13.8, 4.0 Hz, 1H), 7.20–
7.24 (m, 2H), 7.28–7.32 (m, 2H); 13C NMR (75 MHz,
CDCl3): d=19.2 (CH2), 31.2 (CH2), 37.8 (CH2), 45.5 (CH),
53.0 (CH3), 62.1 (C), 76.1 (CH2), 128.9 (2CH), 130.6 (2CH),
133.8 (C), 134.2 (C), 169.6 (C), 212.1 (C); HPLC (Chiralcel
OD, hexane/2-propanol, 90:10, 1.0 mLminÀ1, l=220 nm): tR
(major diastereoisomer)=19.1 min (major), 32.2 min
(minor); HR-MS: m/z=348.0604, calcd. for (C15H16ClNO5 +
Na): 348.0615.
tanecarboxylate (4f): The diastereomers could not be sepa-
rated. 1H NMR (300 MHz, CDCl3): d=1.40–1.94 (m, 8H),
2.49–2.66 (m, 2H), 3.78 (s, 3H), 4.07 (dd, J=9.3, 4.9 Hz,
1H), 4.88–4.99 (m, 2H), 7.14–7.21 (m, 2H), 7.27–7.34 (m,
3H); 13C NMR (75 MHz, CDCl3): d=24.4 (CH2), 25.0
(CH2), 28.8 (CH2), 32.8 (CH2), 41.3 (CH2), 48.4 (CH), 52.3
(CH3), 65.4 (C), 77.7 (CH2), 128.2 (CH), 128.6 (2CH), 129.3
(2CH), 135.5 (C), 171.2 (C), 208.1 (C); HPLC (Chiralcel
OD, hexane/2-propanol, 95:5, 1.0 mLminÀ1, l=220 nm): tR
(major diastereoisomer)=14.6 min (major), 32.8 min
(minor); HR-MS: m/z=319.1428, calcd. for C17H21NO5:
319.1420.
A
ACHTUNGERTN(NUNG 2S,3R)-Methyl 1-[1-(4-fluorophenyl)-2-nitroethyl]-2-oxo-
(4g): The major diastereoisomer was purified by recrystalli-
zation (hexane/AcOEt); [a]2D5: +4.2 (c 0.6 CHCl3, 99% ee);
1H NMR (300 MHz, CDCl3): d=2.25–2.35 (m, 1H), 2.51 (s,
3H), 2.86 (ddd, J=13.3, 7.8, 4.1 Hz, 1H), 3.87 (td, J=8.9,
4.1 Hz, 1H), 4.01–4.09 (m, 1H), 4.51–4.57 (m, 2H), 4.86 (dd,
J=14.2, 12.4 Hz, 1H), 7.32–7.39 (m, 5H); 13C NMR
(75 MHz, CDCl3) d 25.6 (CH2), 26.2 (CH3), 45.6 (CH), 64.6
(C), 65.9 (CH2), 74.9 (CH2), 129.0 (CH), 129.1 (4 CH), 133.0
(C), 173.1 (C), 201.2 (C); HPLC (Chiralcel OD, hexane/2-
propanol, 70:30, 1.0 mLminÀ1, l=220 nm): tR (major diaste-
reoisomer)=20.2 min (major), 51.0 min (minor); HR-MS:
m/z=277.0945, calcd. for C14H15NO5: 277.0950.
cyclopentanecarboxylate (5c): [a]2D5: +30.5 (c 1.5, CHCl3,
95% ee) (lit.[8] [a]D25: À31.3, 94% ee, dr>20:1); 1H NMR
(300 MHz, CDCl3): d=1.81–2.11 (m, 4H), 2.32–2.44 (m,
2H), 3.75 (s, 3H), 4.05 (dd, J=11.0, 4.0 Hz, 1H), 4.97 (dd,
J=13.6, 11.0 Hz, 1H), 5.15 (dd, J=13.6, 4.0 Hz, 1H), 6.96–
7.04 (m, 2H), 7.22–7.29 (m, 2H); 19F NMR (282 MHz,
CDCl3): d=À113.9 (m, 1F); 13C NMR (75 MHz, CDCl3):
d=19.2 (CH2), 31.1 (CH2), 37.8 (CH2), 45.4 (CH), 53.0
2
(CH3), 62.3 (C), 76.3 (CH2), 115.7 (d, JC,F =22.0 Hz, 2 CH),
1
131.0 (C), 131.0 (d, 3JC,F =8.5 Hz, 2CH), 162.4 (d, JC,F
=
247.8 Hz, C), 169.7 (C), 212.2 (C); HPLC (Chiralcel OD,
hexane/2-propanol, 90:10, 1.0 mLminÀ1, l=220 nm): tR
(major diastereoisomer)=15.7 min (major), 28.0 min
(minor); HR-MS: m/z=332.0910, calcd. for (C15H16FNO5 +
Na): 332.0910.
ACHTUNGTRENNUNG(2R,3R)-2-Acetyl-2-(2-nitro-1-phenylethyl)-cyclopentan-
one (4h): The major diastereoisomer was purified by flash
chromatography; [a]D25: À33.3 (c 1.2, CHCl3, 92% ee) (lit.[10]
[a]2D5: À43.3, 99% ee, dr>98:2); 1H NMR (300 MHz,
CDCl3): d=1.67–1.76 (m, 3H), 1.92–2.02 (m, 1H), 2.11–2.22
(m, 1H), 2.32 (s, 3H), 2.52–2.59 (m, 1H), 4.38 (dd, J=11.6,
3.9 Hz, 1H), 4.50 (dd, J=13.6, 3.9 Hz, 1H), 4.86 (dd, J=
13.5, 11.5 Hz, 1H), 7.23–7.34 (m, 5H); 13C NMR (75 MHz,
CDCl3): d=19.3 (CH2), 26.5 (CH3), 27.3 (CH2), 38.5 (CH2),
46.2 (CH), 71.0 (C), 75.5 (CH2), 128.3 (CH), 128.7 (2 CH),
129.4 (2 CH), 134.3 (C), 202.7 (C), 213.1 (C); HPLC (Chiral-
cel OD, hexane/2-propanol, 70:30, 1.0 mLminÀ1, l=
220 nm): tR (major diastereoisomer)=11.4 min (major),
39.2 min (minor); HR-MS: m/z=275.1152, calcd. for
C15H17NO4: 275.1158.
AHCTUNGTREG(NNUN 2S,3R)-Methyl 1-[1-(4-methoxyphenyl)-2-nitroethyl]-2-
oxocyclopentanecarboxylate (5d): [a]2D5: +34.7 (c 1.5, CHCl3,
92% ee) (lit.[8] [a]D25: À38.9, 93% ee, dr>20:1); 1H NMR
(300 MHz, CDCl3): d=1.79–2.07 (m, 4H), 2.29–2.43 (m,
2H), 3.75 (s, 3H), 3.77 (s, 3H), 4.06 (dd, J=11.0, 4.2 Hz,
1H), 4.96 (dd, J=13.4, 11.0 Hz, 1H), 5.11 (dd, J=13.4,
4.0 Hz, 1H), 6.82 (ps d, J=8.8 Hz, 2H), 7.16 (ps d, J=
8.8 Hz, 2H); 13C NMR (75 MHz, CDCl3): d=19.2 (CH2),
30.8 (CH2), 37.9 (CH2), 45.4 (CH), 52.9 (CH3), 55.1 (CH3),
62.5 (C), 76.4 (CH2), 114.0 (2 CH), 126.8 (C), 130.3 (2 CH),
159.2 (C), 169.8 (C), 212.3 (C); HPLC (Chiralpak AS-H,
hexane/2-propanol, 90:10, 1.0 mLminÀ1, l=220 nm): tR
(major diastereoisomer)=22.0 min (minor), 25.8 min
(major); HR-MS: m/z=344.1109, calcd. for (C16H19NO6 +
Na): 344.1110.
ACHTUNGTRENNUNG(2S,3R)-Ethyl 1-benzyl-4-[1-(4-fluorophenyl)-2-nitroeth-
yl]-3-oxopiperidine-4-carboxylate (4i): 1H NMR (300 MHz,
CDCl3): d=1.15 (t, J=7.1 Hz, 3H), 1.54–1.64 (m, 1H),
2.22–2.31 (m, 1H), 2.45 (ddd, J=11.7, 7.5, 4.2 Hz, 1H),
2.70–2.80 (m, 1H), 2.97 (d, J=16.7 Hz, 1H), 3.31 (d, J=
16.7 Hz, 1H), 3.46 (d, J=13.0 Hz, 1H), 3.56 (d, J=13.0 Hz,
1H), 3.95 (dd, J=11.4, 3.5 Hz, 1H), 4.15 (q, J=7.1 Hz, 2H),
4.73 (dd, J=13.3, 11.7 Hz, 1H), 5.05 (dd, J=13.3, 3.4 Hz,
1H), 6.95–7.02 (m, 2H), 7.15–7.25 (m, 4H), 7.27–7.34 (m,
3H); 19F NMR (282 MHz, CDCl3): d=À114.1 (m, 1F);
13C NMR (75 MHz, CDCl3): d=13.8 (CH3), 31.0 (CH2), 45.8
(CH), 48.1 (CH2), 59.0 (C), 60.9 (CH2), 61.9 (CH2), 62.2
AHCTUNGTREG(NNUN 2S,3R)-Methyl 1-[2-nitro-1-(2-nitrophenyl)ethyl]-2-oxo-
cyclopentanecarboxylate (5e): [a]2D5: +108.0 (c 1.7, CHCl3,
97% ee); 1H NMR (300 MHz, CDCl3): d=1.87–2.07 (m,
3H), 2.15–2.23 (m, 2H), 2.42–2.52 (m, 1H), 3.73 (s, 3H),
4.65 (dd, J=10.8, 3.5 Hz, 1H), 5.04 (dd, J=14.3, 10.8 Hz,
1H), 5.34 (dd, J=14.5, 3.5 Hz, 1H), 7.40–7.46 (m, 1H),
7.56–7.61 (m, 1H), 7.77–7.82 (m, 2H); 13C NMR (75 MHz,
CDCl3): d=19.1 (CH2), 33.2 (CH2), 37.5 (CH2), 38.8 (CH),
53.0 (CH3), 61.4 (C), 76.9 (CH2), 124.8 (CH), 129.0 (CH),
129.5 (CH), 131.4 (C), 133.2 (CH), 151.1 (C), 170.3 (C),
212.6 (C); HPLC (Chiralpak AD-H, hexane/2-propanol,
80:20, 0.2 mLminÀ1, l=220 nm): tR (major diastereoiso-
mer)=52.8 min (major), 66.5 min (minor); HR-MS: m/z=
359.0841, calcd. for (C15H16N2O7 +Na): 359.0855.
(CH2), 77.2 (CH2), 115.3 (d, 2JC,F =22.0 Hz, 2CH), 127.5
(CH), 128.3 (2CH), 128.7 (2CH), 130.8 (C), 131.2 (d, JC,F
8.5 Hz, 2CH), 136.6 (C), 162.4 (d, JC,F =247.8 Hz, C), 168.4
(C), 204.3 (C); HPLC (Chiralpak AS-H, hexane/2-propanol,
90:10, 0.2 mLminÀ1, l=220 nm): tR =69.7 min (major),
Adv. Synth. Catal. 2010, 352, 3364 – 3372
ꢃ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3369